Sudarshan Pharma Industries Reports Q3FY26 Earnings Rise as Stock Dips to 52-Week Low

Sudarshan Pharma Industries has reported higher earnings for Q3FY26 and the nine months ended December 31, 2025, even as the share price slipped to a new 52-week low on 29 January 2026, underlining a clear gap between operating performance and market sentiment.

For Q3FY26, net sales rose 16% year-on-year to Rs 168.01 crore, while net profit increased 51% to Rs 4.36 crore. Over the nine-month period, revenue moved up 40% to Rs 482.14 crore and profit after tax climbed 67% to Rs 12.58 crore, versus 9MFY25.

On a full-year comparison with FY24, Sudarshan Pharma Industries posted net sales of Rs 505 crore in FY25, up 9%. Net profit for the year stood at Rs 16 crore, reflecting a 45% rise, showing stronger profitability even though revenue growth stayed in single digits.

Key financial data from the company’s recent disclosures are summarised below for quick reference by investors and analysts tracking Sudarshan Pharma Industries and its earnings trajectory across quarterly, nine-month, and annual periods.

Period	Metric	FY25 / FY26	FY24 / FY25	Change
Q3FY26 vs Q3FY25	Net Sales	Rs 168.01 crore	-	+16%
Q3FY26 vs Q3FY25	Net Profit	Rs 4.36 crore	-	+51%
9MFY26 vs 9MFY25	Net Sales	Rs 482.14 crore	-	+40%
9MFY26 vs 9MFY25	Net Profit	Rs 12.58 crore	-	+67%
FY25 vs FY24	Net Sales	Rs 505 crore	-	+9%
FY25 vs FY24	Net Profit	Rs 16 crore	-	+45%

Despite these earnings gains, Sudarshan Pharma Industries shares touched a fresh 52-week low of Rs 18.50 on 29 January 2026. This came immediately after the Q3FY26 results, suggesting that the market is yet to reward the stronger reported profitability.

Over the 12 months from 29 January 2025 to 29 January 2026, Sudarshan Pharma Industries moved from a 52-week high of about Rs 43.14 to the low of Rs 18.50. This more than 55% slide highlights heavy selling pressure compared with earlier periods of strong buying interest.

Metric	Value	Period
52-week High	~Rs 43.14	29 January 2025
52-week Low	Rs 18.50	29 January 2026
1-year Price Change	-52.72%	Last 12 months
Quarterly Price Change	-14.86%	Last quarter
Weekly Price Change	+3.04%	Last week

According to Trendlyne data, Sudarshan Pharma Industries is trading 3.63% higher intraday on 29 January 2026, even after the 52-week low print. The share price has gained 3.04% in the last week but remains down 14.86% over the previous quarter and 52.72% over one year.

Sudarshan Pharma Industries operates in the specialty chemicals industry in India, manufacturing active pharmaceutical ingredients, engaging employees for pharmaceutical production, and trading chemicals and solvents. The company had a market capitalisation of Rs 481.32 crore as of 29 January 2026, indicating a small-cap profile within the listed specialty chemical space.